ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,287.60
      0.00%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      80.475
      -0.17%
      Bitcoin
      93,312.37
      -1.25%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC

      6. Venus Medtech Hangzhou Inc (PK) (VMTHF) Quote

      Venus Medtech Hangzhou Inc (PK)

      Venus Medtech Hangzhou Inc (PK) (VMTHF)

      USOTC
      0.0108
      0.00
      (0.00%)
      Closed January 13 4:00PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.0108
      Bid
      0.0006
      Ask
      1.82
      Volume
      -
      0.00 Day's Range 0.00
      0.0108 52 Week Range 0.0108
      Market Cap
      4.763M
      Previous Close
      0.0108
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      441,010,235
      Dividend Yield
      -
      PE Ratio
      -0.01
      Earnings Per Share (EPS)
      -1.6
      Revenue
      491.37M
      Net Profit
      -703.75M

      About Venus Medtech Hangzhou Inc (PK)

      Sector
      Electromedical Apparatus
      Industry
      Electromedical Apparatus
      Website
      www.venusmedtech.com
      Headquarters
      Hangzhou, Zhejiang, Chn
      Founded
      -
      Venus Medtech Hangzhou Inc (PK) is listed in the Electromedical Apparatus sector of the OTCMarkets with ticker VMTHF. The last closing price for Venus Medtech Hangzhou (PK) was $0.01. Over the last year, Venus Medtech Hangzhou (PK) shares have traded in a share price range of $ 0.0108 to $ 0.0108.

      Venus Medtech Hangzhou (PK) currently has 441,010,235 shares outstanding. The market capitalization of Venus Medtech Hangzhou (PK) is $4.76 million. Venus Medtech Hangzhou (PK) has a price to earnings ratio (PE ratio) of -0.01.

      Ask ADVFN Intelligence (AI)

      VMTHF Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      26000.01080.01080.010800CS
      52000.01080.01080.01082190.0108CS
      156-4.2392-99.74588235294.254.250.0108706031.91080095CS
      260-10.6388-99.898587740410.649611.47630.01081055177.4865585CS

      VMTHF - Frequently Asked Questions (FAQ)

      What is the current Venus Medtech Hangzhou (PK) share price?
      The current share price of Venus Medtech Hangzhou (PK) is $ 0.0108
      How many Venus Medtech Hangzhou (PK) shares are in issue?
      Venus Medtech Hangzhou (PK) has 441,010,235 shares in issue
      What is the market cap of Venus Medtech Hangzhou (PK)?
      The market capitalisation of Venus Medtech Hangzhou (PK) is USD 4.76M
      What is the 1 year trading range for Venus Medtech Hangzhou (PK) share price?
      Venus Medtech Hangzhou (PK) has traded in the range of $ 0.0108 to $ 0.0108 during the past year
      What is the PE ratio of Venus Medtech Hangzhou (PK)?
      The price to earnings ratio of Venus Medtech Hangzhou (PK) is -0.01
      What is the cash to sales ratio of Venus Medtech Hangzhou (PK)?
      The cash to sales ratio of Venus Medtech Hangzhou (PK) is 0.01
      What is the reporting currency for Venus Medtech Hangzhou (PK)?
      Venus Medtech Hangzhou (PK) reports financial results in CNY
      What is the latest annual turnover for Venus Medtech Hangzhou (PK)?
      The latest annual turnover of Venus Medtech Hangzhou (PK) is CNY 491.37M
      What is the latest annual profit for Venus Medtech Hangzhou (PK)?
      The latest annual profit of Venus Medtech Hangzhou (PK) is CNY -703.75M
      What is the registered address of Venus Medtech Hangzhou (PK)?
      The registered address for Venus Medtech Hangzhou (PK) is ROOM 311, 3/F, BLOCK 2, NO. 88, JIANGLING ROAD, BINJIANG DISTRICT, HANGZHOU, ZHEJIANG
      What is the Venus Medtech Hangzhou (PK) website address?
      The website address for Venus Medtech Hangzhou (PK) is www.venusmedtech.com
      Which industry sector does Venus Medtech Hangzhou (PK) operate in?
      Venus Medtech Hangzhou (PK) operates in the ELECTROMEDICAL APPARATUS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CRGPCalissio Resources Group Inc (CE)
      $ 0.0004
      (39,900.00%)
      		20k
      SMMESmartMetric Inc (PK)
      $ 0.0001
      (9,900.00%)
      		1.25M
      NEOMNeoMedia Technologies Inc (CE)
      $ 0.0001
      (9,900.00%)
      		534.97k
      RRGIReality Racing Inc (CE)
      $ 0.0001
      (9,900.00%)
      		209k
      ELIQQElectriq Power Holdings Inc (CE)
      $ 0.0001
      (9,900.00%)
      		290
      IBKKFImining Technologies Inc (CE)
      $ 0.000001
      (-100.00%)
      		100
      EGIOQEdgio Inc (CE)
      $ 0.000001
      (-99.99%)
      		905
      CYBFCyberfort Software Inc (CE)
      $ 0.000001
      (-99.88%)
      		20k
      CHMJDWaverunner Capital Inc
       0.0045
      (-99.40%)
      		106
      CCTLCoin Citadel (PK)
      $ 0.000001
      (-99.00%)
      		108k
      HMBLHUMBL Inc (PK)
      $ 0.0009
      (0.00%)
      		359.72M
      GRLFGreen Leaf Innovations Inc (PK)
      $ 0.00015
      (50.00%)
      		194.9M
      AITXArtificial Intelligence Technology Solutions Inc (PK)
      $ 0.00375
      (-1.32%)
      		188.36M
      TSOITherapeutic Solutions International Inc (PK)
      $ 0.0002
      (-33.33%)
      		168.26M
      PHILPHI Group Inc (PK)
      $ 0.00025
      (-16.67%)
      		129.87M

      Discussion

      View Full Feed
      DiamondHealer95 DiamondHealer95 3 minutes ago
      I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years 🤪
      KBLB
      DiamondHealer95 DiamondHealer95 6 minutes ago
      We've invested similarly
      KBLB
      sunspotter sunspotter 17 minutes ago
      Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
      VPLM
      Flobewan Flobewan 28 minutes ago
      Marc loved your ides
      tinojax tinojax 29 minutes ago
      I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
      PLUG
      mrfence mrfence 31 minutes ago
      Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
      [yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
      FMCC FNMA
      IVRT IVRT 48 minutes ago
      In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
      BMXI
      DewDiligence DewDiligence 48 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      ENTA
      DewDiligence DewDiligence 49 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      Guido2 Guido2 50 minutes ago
      This is DUE DILIGENCE! Thank you Free Fannie.

      https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
      FNMA
      StockItOut StockItOut 56 minutes ago
      That Xeriant PR excellently written with bullshit:

      ""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

      "the Company used the data to make several key
      XERI
      gitreal gitreal 59 minutes ago
      You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
      BMXI
      RichieBoy RichieBoy 1 hour ago
      Jim wrote a blurb about seeking more US business.

      Help you out any? 🤨
      AFFU
      DesktopDR DesktopDR 1 hour ago
      Any news or updates?
      VPLM
      Tahoe2468 Tahoe2468 1 hour ago
      .0915 by Thursday....... 
      KRTL
      skitahoe skitahoe 1 hour ago
      Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

      According to Google, GBM ha
      NWBO
      fuagf fuagf 1 hour ago
      You are right about the crafty, evil, smart. Authoritarian methods have been in full view
      in capturing America. While we work to do the right things they plot to capture the lot.
      facts_matter14 facts_matter14 1 hour ago
      If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






      .
      SRMX
      StockItOut StockItOut 1 hour ago
      Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
      XERI
      fuagf fuagf 1 hour ago
      He would smother any question with words.
      Shawonsarker84 Shawonsarker84 1 hour ago
      $HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



      https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
      HMBL XTIA
      chen1992 chen1992 1 hour ago
      https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

      https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
      TGLO
      FNM500K FNM500K 1 hour ago
      Oh noooooo.....
      FNMA
      StockItOut StockItOut 2 hours ago
      OTC filings and attorney statements. my error.

      Point that it is on you to prove your claim, that:
      "There's no contract employees. There's no production shafts."

      Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

      I
      BMXI

      Your Recent History

      USOTC
      VMTHF
      Venus Medtech Hangzhou (PK)
      USOTC
      NEFB
      Neffs Bancorp (PK)
      USOTC
      NHNKF
      Nihon Kohden (PK)
      USOTC
      NRXXY
      Nordex (PK)
      BIT
      A09773
      Aldburg Public
      LSE
      46WT
      Municipality 41
      BIT
      P17SA9
      BNP Paribas Issuance
      EU
      ALSAC
      Action Logement Services...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads